Cureage Therapeutics
Develops genetic therapies for people with peripheral nerve diseases, starting with NF1
Highlights
- Young companyFounded 2024
- New on EvolcAdded 2026-11-09
About Cureage Therapeutics
CureAge Therapeutics is developing a genetic therapy for peripheral tumors associated with neurofibromatosis type 1 (NF1). Its approach uses lipid nanoparticles to deliver genetic treatment to tumor Schwann cells, and is being tested in cellular and animal models.
The company is based in London and was founded in 2024.
Product: A lipid nanoparticle-based genetic therapy in development for peripheral tumors associated with NF1.
Jobs at Cureage Therapeutics
More biotech & pharma companies
Cycle Pharmaceuticals
Rare disease medicines and patient support programmes for oncology, neurology, metabolic and immunology conditionsRemote-friendlySalary transparentCyden
Manufacturer of energy-based at-home skin and hair devices for consumer and professional beauty marketsNew on EvolcDaltontx
AI drug discovery platform for pharmaceutical, biotech and CRO discovery teamsYoung companyNew on EvolcDaresbury Proteins
Mammalian recombinant protein production and cell line development for academic and industry research partnersNew on EvolcDloc Biosystems
Organ-on-chip systems and preclinical drug-testing services for pharmaceutical and biomedical research teamsYoung companyNew on EvolcDna Worldwide Group Holdings
DNA testing and related forensic services for individuals, families, immigration applicants and legal casesYoung companyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Microsoft ClarityMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WebflowHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Privacy & consent
- CookiebotHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.